Rotavirus group A genotype circulation patterns across Kenya before and after nationwide vaccine introduction, 2010–2018

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 18 July 2020)

 

Rotavirus group A genotype circulation patterns across Kenya before and after nationwide vaccine introduction, 2010–2018
Kenya introduced the monovalent G1P [8] Rotarix® vaccine into the infant immunization schedule in July 2014. We examined trends in rotavirus group A (RVA) genotype distribution pre- (January 2010–June 2014) an…
Authors: Mike J. Mwanga, Betty E. Owor, John B. Ochieng, Mwanajuma H. Ngama, Billy Ogwel, Clayton Onyango, Jane Juma, Regina Njeru, Elijah Gicheru, Grieven P. Otieno, Sammy Khagayi, Charles N. Agoti, Godfrey M. Bigogo, Richard Omore, O. Yaw Addo, Seheri Mapaseka…
Citation: BMC Infectious Diseases 2020 20:504
Content type: Research article
Published on: 13 July 2020

 

Systems and implementation science should be part of the COVID-19 response in low resource settings

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 18 July 2020)

 

Systems and implementation science should be part of the COVID-19 response in low resource settings
Authors: Mike English, Mosa Moshabela, Jacinta Nzinga, Edwine Barasa, Benjamin Tsofa, Bruno Marchal and Margaret E Kruk
Citation: BMC Medicine 2020 18:219
Content type: Commentary
Published on: 15 July 2020

 

The role of the Stop Transmission of Polio (STOP) program in developing countries: the experience of Kenya

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 18 July 2020)

 

The role of the Stop Transmission of Polio (STOP) program in developing countries: the experience of Kenya
In 1988, the 41st World Health Assembly (WHA) marked the launch of the Global Polio Eradication Initiative (GPEI) for the eradication of polio. A key component of the GPEI has been the development and deployment …
Authors: Brook Tesfaye, Jeevan K. Makam, Kibet Sergon, Iheoma Onuekwusi, Charles Muitherero and Alieu Sowe
Citation: BMC Public Health 2020 20:1110
Content type: Research article
Published on: 14 July 2020

 

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 18 July 2020)

 

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
Meningococcal serogroup B (MenB) is the most common cause of invasive meningococcal disease (IMD) in the United States. The US Advisory Committee on Immunization Practices (ACIP) recommends vaccination of heal…
Authors: Amit Srivastava, Amanda Dempsey, Alex Galitsky, Mansour Fahimi and Liping Huang
Citation: BMC Public Health 2020 20:1109
Content type: Research article
Published on: 14 July 2020

 

Barriers to childhood immunization in sub-Saharan Africa: A systematic review

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 18 July 2020)

 

Barriers to childhood immunization in sub-Saharan Africa: A systematic review
Immunization to prevent infectious diseases is a core strategy to improve childhood health as well as survival. It remains a challenge for some African countries to attain the required childhood immunization c…
Authors: Joseph Benjamin Bangura, Shuiyuan Xiao, Dan Qiu, Feiyun Ouyang and Lei Chen
Citation: BMC Public Health 2020 20:1108
Content type: Research article
Published on: 14 July 2020

 

The Pathway Forward: Insights on Factors that Facilitate Research with Pregnant Women

Ethics & Human Research
Volume 42, Issue 4 Pages: 1-40 July–August 2020
https://onlinelibrary.wiley.com/toc/25782363/current

 

Pregnant Women Covid‐19 Vaccine Challenge Trials Lotteries
Articles
The Pathway Forward: Insights on Factors that Facilitate Research with Pregnant Women
Anna C. Mastroianni, Robert Franceschini, Sarah L. Wicks, Leslie Meltzer Henry
Pages: 2-16
First Published: 16 July 2020

 

Pregnant Women in Trials of Covid‐19: A Critical Time to Consider Ethical Frameworks of Inclusion in Clinical Trials

Ethics & Human Research
Volume 42, Issue 4 Pages: 1-40 July–August 2020
https://onlinelibrary.wiley.com/toc/25782363/current

 

Articles
Free Access
Pregnant Women in Trials of Covid‐19: A Critical Time to Consider Ethical Frameworks of Inclusion in Clinical Trials
Ruth Farrell, Marsha Michie, Rachel Pope
Pages: 17-23
First Published: 20 June 2020

 

Supporting communities of practice – A Journey to effective problem-solving

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 18 July 2020]

 

Open Letter metrics AWAITING PEER REVIEW
Supporting communities of practice – A Journey to effective problem-solving [version 1; peer review: awaiting peer review]
Christina Hanschke, James Baer, Alok Gangaramany, Janneke Verheijen, Nduku Kilonzo, Bryan Okiya, Leonard Kibe Ranji, Stephen Amolo Amolo, Simon Zwane, Rejoice Nkambule, Violet Buluma, Sylvia Ojoo, Susan Kim, Sharon Kibwana, Mark Dybul, Steve Kretschmer
Peer Reviewers Invited
Funder
Bill and Melinda Gates Foundation
PUBLISHED 17 Jul 2020

 

Direct and indirect effects of COVID-19 on perinatal outcomes in low- and middle-income countries

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 18 July 2020]

 

Open Letter metrics AWAITING PEER REVIEW
Direct and indirect effects of COVID-19 on perinatal outcomes in low- and middle-income countries [version 1; peer review: awaiting peer review]
Felisita Tupou Ratu, Kathleen Ryan, Netsanet Workneh Gidi, Ilisapeci Vereti, Tsinuel Girma, Jeremy Oats, Ingrid Bucens, Alexandra Robinson, Claire von Mollendorf, Fiona M. Russell
Peer Reviewers Invited
Funder
Bill and Melinda Gates Foundation
PUBLISHED 16 Jul 2020

How to engage communities on a large scale? Lessons from World Mosquito Program in Rio de Janeiro, Brazil

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 18 July 2020]

 

Open Letter metrics AWAITING PEER REVIEW
How to engage communities on a large scale? Lessons from World Mosquito Program in Rio de Janeiro, Brazil [version 1; peer review: awaiting peer review]
Guilherme B. Costa, Ruth Smithyman, Scott L. O’Neill, Luciano A. Moreira
Peer Reviewers Invited
Funders
Bill and Melinda Gates Foundation
Ministério da Saúde Brasil
PUBLISHED 17 Jul 2020

 

Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 18 July 2020]

 

Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Authors: Long Chiau Ming, Zahid Hussain, Siang Fei Yeoh, David Koh and Kah Seng Lee
Content type: Letter to the Editor
16 July 2020
The World Health Organisation Western Pacific Region countries were declared free of polio in 2000 until a polio outbreak involving 305 cases occurred in Indonesia in 2006. It was not until 2014 that the World Health Organisation South East Asia region was officially declared polio-free again. However, in February 2019, the Global Polio Eradication Initiative announced a new circulating vaccine-derived poliovirus outbreak in the Papua province of Indonesia. To make matter worse, the outbreak responses were tardy and led to transmission among migrating communities to other cities. The pressing regional issues of polio outbreak caused by circulating vaccine-derived poliovirus and use of oral polio vaccine have not been well presented. Our letter highlighted the suboptimal outbreak responses as well as the necessity of cross-border vaccination to curb continued poliovirus transmission.

 

Social innovation for health: engaging communities to address infectious diseases

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 18 July 2020]

 

Social innovation for health: engaging communities to address infectious diseases
Universal health coverage emphasises the value of the community-based delivery of health services to ensure that underserved populations have access to care. In areas where infectious diseases are endemic, the…
Authors: Phyllis Dako-Gyeke, Uche V. Amazigo, Beatrice Halpaap and Lenore Manderson
Citation: Infectious Diseases of Poverty 2020 9:98
Content type: Commentary
Published on: 18 July 2020

 

Estimation of exponential growth rate and basic reproduction number of the coronavirus disease 2019 (COVID-19) in Africa

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 18 July 2020]

 

Estimation of exponential growth rate and basic reproduction number of the coronavirus disease 2019 (COVID-19) in Africa
Since the first case of coronavirus disease 2019 (COVID-19) in Africa was detected on February 14, 2020, the cumulative confirmations reached 15 207 including 831 deaths by April 13, 2020. Africa has been desc…
Authors: Salihu S. Musa, Shi Zhao, Maggie H. Wang, Abdurrazaq G. Habib, Umar T. Mustapha and Daihai He
Citation: Infectious Diseases of Poverty 2020 9:96
Content type: Research Article
Published on: 16 July 2020

 

Coronavirus 2019 and health systems affected by protracted conflict: The case of Syria

International Journal of Infectious Diseases
July 2020 Volume 96, p1-714
https://www.ijidonline.com/issue/S1201-9712(20)X0008-7

 

Coronavirus (COVID-19) Collection
Coronavirus 2019 and health systems affected by protracted conflict: The case of Syria
Aula Abbara, Diana Rayes, Ola Fahham, Omar Alrashid Alhiraki, Munzer Khalil, Abdulrahman Alomar, Ahmad Tarakji
p192–195
Published online: May 7, 2020

 

Mitigating lockdown challenges in response to COVID-19 in Sub-Saharan Africa

International Journal of Infectious Diseases
July 2020 Volume 96, p1-714
https://www.ijidonline.com/issue/S1201-9712(20)X0008-7

 

Mitigating lockdown challenges in response to COVID-19 in Sub-Saharan Africa
Leonard E.G. Mboera, George O. Akipede, Amitava Banerjee, Luis E. Cuevas, Thomas Czypionka, Mishal Khan, Richard Kock, David McCoy, Blandina T. Mmbaga, Gerald Misinzo, Elizabeth H. Shayo, Meru Sheel, Calvin Sindato, Mark Urassa
p308–310
Published online: May 10, 2020

 

Monoclonal Antibodies for Prevention and Treatment of COVID-19

JAMA
July 14, 2020, Vol 324, No. 2, Pages 121-206
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Monoclonal Antibodies for Prevention and Treatment of COVID-19
Mary Marovich, MD; John R. Mascola, MD; Myron S. Cohen, MD
free access has multimedia
JAMA. 2020;324(2):131-132. doi:10.1001/jama.2020.10245
This Viewpoint discusses the potential role of neutralizing monoclonal antibodies (MAbs) as a treatment for coronavirus disease 2019 (COVID-19) and as a means of prevention in high-risk populations, and it also raises possible limitations of the approach that need to be disproven or addressed for the strategy to be effective.

 

The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020

JAMA
July 14, 2020, Vol 324, No. 2, Pages 121-206
https://jamanetwork.com/journals/jama/currentissue

 

COVID-19: Beyond Tomorrow
The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020
Joshua M. Sharfstein, MD; Christopher C. Morphew, PhD
free access has active quiz has multimedia has audio
JAMA. 2020;324(2):133-134. doi:10.1001/jama.2020.10175
This Viewpoint proposes a policy framework for reopening of US primary, middle, and high schools (kindergarten through 12th grade) in fall 2020, including ramping up community public health responses in the summer, symptom screening of students, and privileging return-to-school decisions for younger children and others at risk for education disparities.
Audio Author Interview: Coronavirus Q&A: Opening School in the Fall
Audio Author Interview: The Next COVID-19 Phase

 

Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among RegulatorsA National Academies Report

JAMA
July 14, 2020, Vol 324, No. 2, Pages 121-206
https://jamanetwork.com/journals/jama/currentissue

 

Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among RegulatorsA National Academies Report
Lawrence O. Gostin, JD; Alastair J. Wood, MD; Patricia A. Cuff, MS, MPH
JAMA. 2020;324(2):145-146. doi:10.1001/jama.2019.21793
This Viewpoint summarizes recommendations from a 2020 National Academies of Sciences, Engineering, and Medicine (NASEM) committee report on ways to improve regulatory oversight of drugs in an era of global pharmaceutical research and development.

 

Sustainability, Business, and Health

JAMA
July 14, 2020, Vol 324, No. 2, Pages 121-206
https://jamanetwork.com/journals/jama/currentissue

 

Sustainability, Business, and Health
George Serafeim, DBA; Amanda M. Rischbieth, PhD; Howard K. Koh, MD, MPH
has audio
JAMA. 2020;324(2):147-148. doi:10.1001/jama.2020.8714
This Viewpoint discusses examples of how many private sector businesses have aligned their core missions with civil and human rights and sustainability reforms, and emphasizes the importance of engaging the sector in achieving public health goals and accelerating worldwide recovery from the COVID-19 pandemic.

 

Harnessing behavioural science in public health campaigns to maintain ‘social distancing’ in response to the COVID-19 pandemic: key principles (8 May, 2020) Free

Journal of Epidemiology & Community Health
August 2020 – Volume 74 – 8
https://jech.bmj.com/content/74/8

 

Commentary
Harnessing behavioural science in public health campaigns to maintain ‘social distancing’ in response to the COVID-19 pandemic: key principles (8 May, 2020) Free
Chris Bonell, Susan Michie, Stephen Reicher, Robert West, Laura Bear, Lucy Yardley, Val Curtis, Richard Amlôt, G James Rubin

 

Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian’s perspective

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 18 July 2020]

 

Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian’s perspective
Drug repositioning is the scientific strategy of investigating existing drugs for additional clinical indications. The advantages of drug repositioning are that it benefits patients and that it adds new indica…
Authors: A. B. Bayoumy, N. K. H. de Boer, A. R. Ansari, F. Crouwel and C. J. J. Mulder
Citation: Journal of Pharmaceutical Policy and Practice 2020 13:45
Content type: Review
Published on: 17 July 2020

 

Successful smallpox eradication: what can we learn to control COVID-19?

Journal of Travel Medicine
Volume 27, Issue 4, May 2020
https://academic.oup.com/jtm/issue/27/4

 

Editorial
Successful smallpox eradication: what can we learn to control COVID-19?
D L Heymann, MD, Profeseor, Annelies Wilder-Smith, MD, Professor
Journal of Travel Medicine, Volume 27, Issue 4, May 2020, taaa090, https://doi.org/10.1093/jtm/taaa090
The public health community needs to learn from history and needs to regain its ability to do shoe-leather public health. If we come together collectively and use the public health tools that we have at hand, we will be successful in containing COVID-19 despite geopolitical tensions, just as we were successful in eradicating smallpox despite the Cold War at the time.

 

Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomized controlled trial

Journal of Travel Medicine
Volume 27, Issue 4, May 2020
https://academic.oup.com/jtm/issue/27/4

 

Original Article
Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomized controlled trial
Al-Mamoon Badahdah, PhD, Marwan A Bakarman, FFCM, Ameneh Khatami, MD, Mohamed Tashani, PhD, Osamah Barasheed, MPH
Journal of Travel Medicine, Volume 27, Issue 4, May 2020, taaa032, https://doi.org/10.1093/jtm/taaa032

 

Socio-demographic and epidemiological consideration of Africa’s COVID-19 response: what is the possible pandemic course?

Nature Medicine
Volume 26 Issue 7, July 2020
https://www.nature.com/nm/volumes/26/issues/7

 

Comment | 11 June 2020
Socio-demographic and epidemiological consideration of Africa’s COVID-19 response: what is the possible pandemic course?
Africa is said to be the next possible hotspot for COVID-19. However, we believe this is still preventable.
Bamba Gaye, Stéphanie Khoury[…] & Xavier Jouven

 

COVID-19 in Africa: the spread and response

Nature Medicine
Volume 26 Issue 7, July 2020
https://www.nature.com/nm/volumes/26/issues/7

 

Comment | 11 June 2020
COVID-19 in Africa: the spread and response
Given the current trends in incidence and underlying healthcare systems vulnerabilities, Africa could become the next epicenter of the COVID-19 pandemic. As the pandemic transitions to more widespread community transmission, how can the lessons learned thus far be consolidated to effectively curb the spread of COVID-19 while minimizing social disruption and negative humanitarian and economic consequences?
Marguerite Massinga Loembé, Akhona Tshangela[…] & John N. Nkengasong

 

Disproportionate impact of the COVID-19 pandemic on immigrant communities in the United States

PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 18 July 2020)

 

Disproportionate impact of the COVID-19 pandemic on immigrant communities in the United States
Eva Clark, Karla Fredricks, Laila Woc-Colburn, Maria Elena Bottazzi, Jill Weatherhead
Viewpoints | published 13 Jul 2020 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0008484

 

Retraction: Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake

PLoS One
http://www.plosone.org/
[Accessed 18 July 2020]

 

Retraction: Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake
Steven Brownstone, Alison Connor, Daniel Stein, the PLOS ONE Editors
Retraction | published 14 Jul 2020 PLOS ONE
https://doi.org/10.1371/journal.pone.0236542

 

COVID-19 policies: Remember measles

Science
17 July 2020 Vol 369, Issue 6501
http://www.sciencemag.org/current.dtl

 

Letters
COVID-19 policies: Remember measles
By Debarati Guha-Sapir, Maria Moitinho de Almeida, Mory Keita, Gregg Greenough, Eran Bendavid
Science17 Jul 2020 : 261
Nearly 120 million children in 37 countries are at risk of missing their measlescontaining vaccine (MCV) shots this year, as preventive and public health campaigns take a back seat to policies put in place to contain coronavirus disease 2019 (COVID-19) (1). In March, the World Health Organization (WHO) issued guidelines indicating that mass vaccination campaigns should be put on hold to maintain physical distancing and minimize COVID-19 transmission (2). The disruption of immunization services, even for short periods, will lead to more susceptible individuals, more communities with less than the 95% MCV coverage needed for herd immunity, and therefore more measles outbreaks globally. A mere 15% decrease in routine measles vaccinations—a plausible result of lockdowns and disruption of health services—could raise the burden of childhood deaths by nearly a quarter of a million in poorer countries (3). Solutions for COVID-19, especially among the global poor, cannot include forgoing vaccinations.

Suspending mass vaccination campaigns is particularly pernicious in countries embroiled in conflict. Malnutrition among children and mothers in these regions is all too common—and increases mortality for those also infected by measles (4). In the conflict-affected regions of Ituri and North Kivu in eastern Democratic Republic of the Congo (DRC) alone, COVID-19 precautions are expected to delay measles vaccinations for nearly a million children (1).

COVID-19 mortality has so far been low in most poorer countries and trivial compared with the immediate risk of mortality due to measles. In the DRC, for example, the total number of deaths due to COVID-19 as of June was 37 (5), whereas the 2019 measles outbreak in the conflict region of eastern DRC killed more than 6000 people in a matter of months, mostly children (6). In some poor countries, more than 40% of the population is younger than 14 years old (7). This demographic group is the least affected by COVID-19 (in terms of symptoms, mortality, and transmission) (8) but at serious risk of measles (9). In addition, because many people in these countries live in cramped housing with unavoidable crowding, policies to minimize COVID-19 at the expense of measles prevention may not even be effective (10).

Postponement of measles campaigns prioritizes panic-driven policies for controlling COVID-19 without consideration of these policies’ costs. If children are not immunized within the correct age window, they forgo benefits of lifelong immunity (11). Whole cohorts of children may be left unprotected. We must balance priorities of containing COVID-19 with efforts to control other high-transmission disease threats in poor countries, especially those affected by conflict.

 

outcomes

Systematic Reviews
https://systematicreviewsjournal.biomedcentral.com/articles
[Accessed 18 July 2020]

 

Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol
Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general popula…
Authors: Binny Thomas, Abdulrouf Pallivalapila, Wessam El Kassem, Asma Tarannum, Fatema Al Hail, Mohammed Rijims, Hussain Parappil, Arabo Ibrahim Bayo, Shamsa Ahmad, Zachariah Nazar, Derek Stewart and Moza Al Hail
Citation: Systematic Reviews 2020 9:161
Content type: Protocol
Published on: 18 July 2020

 

WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines

Vaccine
Volume 38, Issue 32 Pages 4917-5076 (6 July 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/32

 

Conference info Open access
WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines
Dianliang Lei, Elwyn Griffiths, Javier Martin

 

Human Papillomavirus Vaccines: An Updated Review

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 18 July 2020)

 

Open Access Review
Human Papillomavirus Vaccines: An Updated Review
by Liqin Cheng , Yan Wang and Juan Du
Vaccines 2020, 8(3), 391; https://doi.org/10.3390/vaccines8030391 (registering DOI) – 16 Jul 2020
Abstract
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated information about current HPV vaccines…

Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 18 July 2020
[No new, unique, relevant content]

 

BBC
http://www.bbc.co.uk/
Accessed 18 July 2020
Russia’s UK ambassador rejects coronavirus vaccine hacking allegations
Russia’s representative in the UK also dismisses suggestions of interference in British politics.
18 Jul 2020

 

The Economist
http://www.economist.com/
Accessed 18 July 2020
[No new, unique, relevant content]

 

Financial Times
http://www.ft.com/home/uk
Accessed 18 July 2020
Interview Coronavirus treatment
World must pick sides in vaccines battle, says Russian wealth fund chief
Kirill Dmitriev says his country will be among those to develop a vaccine soon
The head of Russia’s sovereign wealth fund said his country and a handful of other leading powers would develop viable Covid-19 vaccines in the new year, forcing the rest of the world to chose which of them to align with. Kirill Dmitriev, chief executive of the state-run Russian Direct Investment Fund, also warned that public health could be put at risk and coronavirus immunity divided by geopolitical faultlines if countries chose “political biases” instead of sourcing the most effective defences against the virus. “Six months from now, we will be in a situation where a few countries will have vaccines, and we believe those countries will be the UK, Russia, China and the US,” Mr Dmitriev told the Financial Times in an interview. “And basically other countries will decide . . . which vaccine to buy . . . and who do you trust?”…
July 17, 2020

 

Forbes
http://www.forbes.com/
Accessed 18 July 2020
[No new, unique, relevant content]

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 18 July 2020
Snapshot
Predicting the Next Pandemic
The United States Needs an Early Warning System for Infectious Diseases
By Andrew S. Natsios
July 14, 2020

 

Foreign Policy
http://foreignpolicy.com/
Accessed 18 July 2020 | [No new, unique, relevant content]
Argument
The Coronavirus Pandemic Will Transform How Vaccines Are Made
The COVID-19 crisis could enable the improvement of the global vaccine system for all diseases. Here’s how that could happen.
By Saad B. Omer
| July 16, 2020, 12:50 PM

 

The Guardian
http://www.guardiannews.com/
[No new, unique, relevant content]

 

New Yorker
http://www.newyorker.com/
Accessed 18 July 2020
[No new, unique, relevant content]

 

New York Times
http://www.nytimes.com/
Accessed 18 July 2020
Health
Mistrust of a Coronavirus Vaccine Could Imperil Widespread Immunity
Billions are being poured into developing a shot, but the rapid timetable and President Trump’s cheerleading are creating a whole new group of vaccine-hesitant patients.
By Jan Hoffman July 18

Health
Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine
In Boston and in the Netherlands, scientists are racing to build a vaccine against the virus strangling the world.
By Carl Zimmer

Business
In Coronavirus Vaccine Race, China Strays From the Official Paths
Beijing is offering several vaccine candidates to employees of state-owned companies and the armed forces, while also conducting clinical trials in other countries.
By Sui-Lee Wee and Mariana Simões July 16

Politics
Chief Vaccine Scientist Will Not Be Forced to Disclose Pharmaceutical Stocks
Dr. Moncef Slaoui, the chief adviser for the Trump administration’s coronavirus vaccine program, can remain a government contractor, thus shielding him from disclosure rules.
By Noah Weiland

 

Washington Post
https://www.washingtonpost.com/
Accessed 18 July 2020
Social Issues
Anti-vaccination leaders fuel black mistrust of medical establishment as covid-19 kills people of color
The memory of the horrific Tuskegee syphilis study makes some African Americans suspicious of a coronavirus vaccine
By Peter Jamison July 17, 2020

 

Think Tanks et al

Think Tanks et al

Brookings
http://www.brookings.edu/
Accessed 18 July 2020
[No new relevant content]

Center for Global Development [to 18 July 2020]
http://www.cgdev.org/page/press-center
Accessed 18 July 2020
[No new relevant content]

Chatham House [to 18 July 2020]
https://www.chathamhouse.org/
Members Event
Webinar: Weekly COVID-19 Pandemic Briefing – Perspective from the Pharmaceutical Industry
22 July 2020
As countries grapple with how best to tackle the COVID-19 pandemic and the reverberations it is sending through their societies and economies, understanding of how the virus is behaving, and what measures might best combat it, continues…

 

CSIS
https://www.csis.org/
Accessed 18 July 2020
Upcoming Event
Online Event: A Conversation with Dr. Anthony Fauci
July 24, 2020

Newsletter
Asia’s Covid-19 Lessons for The West: Public Goods, Privacy, and Social Tagging
July 16, 2020 | By Victor Cha

 

Council on Foreign Relations
http://www.cfr.org/
Accessed 18 July 2020
Global Governance
The Politics of a COVID-19 Vaccine
Governments must prepare now to avoid “catastrophic success” once a Covid-19 vaccine emerges
…No vaccine can be expected to produce complete or lasting immunity in all who take it. Millions will refuse to get vaccinated. And there is the brute fact that there are nearly eight billion men, women, and children on the planet. Manufacturing eight billion doses (or multiples of that if more than one dose is needed) of one or more vaccines and distributing them around the globe could require years, not months….
by Richard N. Haass July 14, 2020

 

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 18 July 2020
July 16, 2020 News Release
More Than 3 Million People Age 65 or Older Live with School-Age Children, and Could Be at Heightened Risk of COVID-19 Infection if Children Bring the Virus Home from School
About 3.3 million adults age 65 or older live in a household with school-age children, a factor that state and local officials may want to take into account when deciding when and how fully to re-open schools this fall, a new KFF analysis finds. These older adults, who represent roughly…

 

Vaccines and Global Health: The Week in Review :: 11 July 2020

Independent evaluation of global COVID-19 response announced – WHO

Milestones :: Perspectives :: Research

Independent evaluation of global COVID-19 response announced – WHO
9 July 2020 News release Geneva, Switzerland
WHO Director-General today announced the initiation of the Independent Panel for Pandemic Preparedness and Response (IPPR) to evaluate the world’s response to the COVID-19 pandemic.

In remarks to WHO Member States, Director-General Tedros Adhanom Ghebreyesus said the Panel will be co-chaired by former Prime Minister of New Zealand Helen Clark and former President of Liberia Ellen Johnson Sirleaf. Prime Minister Clark went to on lead the United Nations Development Programme and President Sirleaf is a recipient of the Nobel Peace Prize.

Operating independently, they will choose other Panel members as well as members of an independent secretariat to provide support.

“Prime Minister Clark and President Sirleaf were selected through a process of broad consultation with Member States and world experts. I cannot imagine two more strong-minded, independent leaders to help guide us through this critical learning process.” said Dr. Tedros in his speech.

At the historic 73rd World Health Assembly in May, Member States adopted a landmark resolution that called on WHO to initiate an independent and comprehensive evaluation of the lessons learned from the international health response to COVID-19.

“This is a time for self-reflection, to look at the world we live in and to find ways to strengthen our collaboration as we work together to save lives and bring this pandemic under control,” said Dr Tedros. “The magnitude of this pandemic, which has touched virtually everyone in the world, clearly deserves a commensurate evaluation.”

Dr Tedros proposed that a Special Session of the Executive Board be called in September to discuss the Panel’s progress. In November the Panel will present an interim report at the resumption of the World Health Assembly.

In January 2021, the Executive Board will hold its regular session, where the Panel’s work will be further discussed; and in May of next year, at the World Health Assembly, the panel will present its substantive report.

The Director-General noted that the Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme will also continue its existing work.

“Even as we fight this pandemic, we must be readying ourselves for future global outbreaks and the many other challenges of our time such as antimicrobial resistance, inequality and the climate crisis,” said Dr Tedros. “COVID-19 has taken so much from us. But it is also giving us an opportunity to break with the past and build back better.”